88U-13177-23403
5 vaccinations
7 coded responses
32 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 751 / TX
- Registered
- 2021-02-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-08
Dose 1 — Pfizer-BioNTech
-
2021-02-09
Registered in v-safe
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-22
-
2021-03-01
Dose 2 — Pfizer-BioNTech
- 2021-03-01
-
2021-03-02
Survey response — days 1–6 daily, dose 2MedDRA: Eye pain, Photophobia — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: Eyes hurt, light sensitivityMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-05
Survey response — days 1–6 daily, dose 2MedDRA: Photophobia — Feeling: Fair · HeadacheFree text: Sensitivity to lightMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Survey response — days 1–6 daily, dose 2MedDRA: Photophobia — Feeling: Good · Fatigue or tirednessFree text: Sensitivity to lightMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-07
Survey response — days 1–6 daily, dose 2MedDRA: Depression — Feeling: GoodFree text: The third and fourth day following the vaccination, I was very depressed.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
- 2021-04-12
- 2021-05-31
- 2021-09-01
-
2021-11-10
Dose 3 — Pfizer-BioNTech
-
2022-04-22
Dose 4 — Pfizer-BioNTech
-
2022-09-29
Dose 5 — Pfizer-BioNTech
-
2022-10-04
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-05
Health check-in — days 1–6 daily, dose 5Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-06
Health check-in — day 7, dose 5Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-10-13
- 2022-10-20
- 2022-10-27
-
2022-11-03
Survey response — day 35, dose 5MedDRA: Surgery, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Biopsy of right temporal artery in effort to diagnose giant cell arteritis. Biopsy was negative. · Healthcare visit (other): Day surgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-11-03
Report sent to call center — day 35, dose 5Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-11-04
-
2022-11-10
Survey response — day 42, dose 5MedDRA: Mobility decreased, Polymyalgia rheumatica, Red blood cell sedimentation rate increased — Feeling: GoodFree text: Diagnosis: poly myalgia rheumatica Had right temporal artery biopsy for giant cell arteritis, negative. 10/28 /20. Treatment: prednisone or hydroxychlorophine ESR chronically high, restricted mobility. Health records complete, No COVID.MedDRA releases: 2024-11 · check-in free text available
-
2023-03-30
Survey response — 6 months, dose 5MedDRA: Bronchitis, Office visit, Pyrexia — Feeling: Fair · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-03-30
Report sent to call center — 6 months, dose 5Get care from a doctor or other healthcare professional1 call case(s)
- 2023-03-31
- 2023-03-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-08 | Pfizer-BioNTech | |
| 2 | 2021-03-01 | Pfizer-BioNTech | |
| 3 | 2021-11-10 | Pfizer-BioNTech | No |
| 4 | 2022-04-22 | Pfizer-BioNTech | No |
| 5 | 2022-09-29 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Eyes hurt, light sensitivity
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Sensitivity to light
Systemic reaction (other): Sensitivity to light
Systemic reaction (other): The third and fourth day following the vaccination, I was very depressed.
Release 12 — day 35, dose 5
Symptoms: Biopsy of right temporal artery in effort to diagnose giant cell arteritis. Biopsy was negative.
Healthcare visit (other): Day surgery
Release 12 — day 42, dose 5
Symptoms: Diagnosis: poly myalgia rheumatica Had right temporal artery biopsy for giant cell arteritis, negative. 10/28 /20. Treatment: prednisone or hydroxychlorophine ESR chronically high, restricted mobility. Health records complete, No COVID.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Surgery | · | · | ✓ |
| SD | Bronchitis | · | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Polymyalgia rheumatica | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Red blood cell sedimentation rate increased | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Depression | ✓ | ✓ | ✓ |
| SRO | Eye pain | ✓ | ✓ | ✓ |
| SRO | Photophobia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release